3rd Quarter - Report

VENABLE LLP for ENDO PHARMACEUTICALS INC

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Tax legislation designed to encourage targeted research and investment in life sciences.

LobbyistCovered position, as disclosed
SAMUEL OLCHYK —
ROBERT L SMITH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

The Life Sciences Jobs and Investment Act of 2011.

LobbyistCovered position, as disclosed
ROBERT L SMITH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

General issues affecting the pharmaceutical industry The Life Sciences Investment Act

LobbyistCovered position, as disclosed
ROBERT L SMITH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.